Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

In vitro and in vivo antitumor properties of 7-epidocetaxel, a major impurity of docetaxel

Ke Jiang^1,2, Haoran Wang^1,2, Qing Li^1,2, Ahu Yuan^1-4, Yiqiao Hu^1-4 , Jinhui Wu^1-4

¹State Key Laboratory of Pharmaceutical Biotechnology; ²Institute of Drug R & D, Medical School of Nanjing University; ³Jiangsu Key Laboratory for Nano Technology; ⁴Jiangsu R & D Platform for Controlled & Targeted Drug Delivery, Nanjing University, Nanjing 210093, China.

For correspondence:- Yiqiao Hu Email: wuj@nju.edu.cn

Accepted: 29 August 2018 Published: 30 September 2018

Citation: Jiang K, Wang H, Li Q, Yuan A, Hu Y, Wu J. In vitro and in vivo antitumor properties of 7-epidocetaxel, a major impurity of docetaxel. Trop J Pharm Res 2018; 17(9):1789-1795 doi: 10.4314/tjpr.v17i9.16

© 2018 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the antitumor properties and toxicity of 7-epi docetaxel (7-epi DTX) as an active pharmaceutical ingredient, and in formulations.

Methods: Docetaxel-loaded albumin nanoparticles (DTX NPs) were prepared by freeze-drying, while 7-epi DTX was detected and isolated by high performance liquid chromatography (HPLC). Their antitumor properties were evaluated in vitro in CT26 cells and in vivo in BALB/c sk-ov-3 xenograft nude mice model. The tissues were histological examined.

Results: The in vivo antitumor effects of DTX NPs at different doses of 7-epi DTX were similar. Moreover, the in vitro anti-cancer effect of 7-epi DTX was comparable to that of DTX. However, the in vivo antitumor effectiveness of 7-epi DTX was inferior to that of DTX. In toxicity studies, 7-epi DTX did not elicit any acute toxic effects both as active pharmaceutical ingredients, and as a component of formulations.

Conclusion: The results indicate that 7-epi DTX does not elicit acute toxic effects both as an active pharmaceutical ingredient and in bulk formulations. The antitumor property of 7-epi DTX is less than that of DTX.

Keywords: 7-Epidocetaxel, Impurity, Antitumor properties, Toxicity